Jim Wassil Vaxcyte, Inc. (PCVX) insider trading activity

Jim Wassil is CHIEF OPERATING OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 151,916 shares of PCVX, which is worth approximately $5.74 Million. The most recent transaction as insider was on Jun 03, 2024, when has been sold 3,000 shares (Common Stock) at a price of $72.39 per share, resulting in proceeds of $217,170. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K

26.15% 3M change

30.41% 12M change

Total Value Held $5.74 Million

Jim Wassil Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	SELL Open market or private sale	$217,170 $72.39 p/Share	3,000 Reduced 1.39%	213,503 Common Stock
May 01 2024	SELL Open market or private sale	$186,870 $62.29 p/Share	3,000 Reduced 1.37%	215,462 Common Stock
Apr 17 2024	BUY Exercise of conversion of derivative security	$18,997 $5.35 p/Share	3,551 Added 1.58%	221,840 Common Stock
Apr 01 2024	SELL Open market or private sale	$200,640 $66.88 p/Share	3,000 Reduced 1.36%	218,289 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$103,434 $69.7 p/Share	1,484 Reduced 0.67%	221,289 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	4,099 Added 1.81%	222,773 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$155,835 $71.55 p/Share	2,178 Reduced 0.99%	218,674 Common Stock
Mar 01 2024	SELL Open market or private sale	$221,400 $73.8 p/Share	3,000 Reduced 1.34%	220,852 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	20,000 Added 8.2%	223,852 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	$67,559 $2.42 p/Share	27,917 Added 12.05%	203,852 Common Stock
Feb 01 2024	SELL Open market or private sale	$221,190 $73.73 p/Share	3,000 Reduced 1.68%	175,935 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.65%	178,935 Common Stock
Jan 02 2024	SELL Open market or private sale	$191,790 $63.93 p/Share	3,000 Reduced 1.68%	175,935 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.65%	178,935 Common Stock
Dec 01 2023	SELL Open market or private sale	$155,940 $51.98 p/Share	3,000 Reduced 1.68%	175,935 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.65%	178,935 Common Stock
Nov 01 2023	SELL Open market or private sale	$143,010 $47.67 p/Share	3,000 Reduced 1.68%	175,935 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.65%	178,935 Common Stock
Oct 12 2023	BUY Exercise of conversion of derivative security	$12,100 $2.42 p/Share	5,000 Added 2.76%	175,935 Common Stock
Oct 02 2023	SELL Open market or private sale	$151,980 $50.66 p/Share	3,000 Reduced 1.72%	170,935 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.7%	173,935 Common Stock
Sep 22 2023	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.72%	170,935 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$108,681 $51.0 p/Share	2,131 Reduced 1.25%	167,935 Common Stock
Sep 01 2023	SELL Open market or private sale	$159,180 $53.06 p/Share	3,000 Reduced 1.73%	170,066 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$7,260 $2.42 p/Share	3,000 Added 1.7%	173,066 Common Stock

Also insider at

ICVX

Icosavax, Inc. Healthcare

Jim Wassil

CHIEF OPERATING OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account